Walmart Will Cover Diabetes Drugs at No Cost in 2027
The company plans to provide free access to over 250 medications for its 1.6 million U.S. employees.
Updated on Oct. 13, 2026 in Diabetes
Live Poll
Do you believe large employers have a responsibility to expand healthcare benefits for their employees?
Beginning in 2027, Walmart will offer over 250 prescription drugs to its U.S. workforce at no cost, including treatments for Type 2 diabetes. This initiative covers medications such as Ozempic and Mounjaro, provided employees receive prior approval.
Why it matters
Access to expensive chronic disease medications often dictates treatment adherence and health outcomes, making this benefit a significant change for employees managing conditions like diabetes. The expansion arrives as many other employers are reconsidering their coverage for costly GLP-1 drugs.
Walmart announced this coverage expansion for its 1.6 million employees, contrasting with reports that eight in ten employers blame drug costs for rising insurance expenses. It remains unknown which specific treatments will be included beyond the identified diabetes and neurological medications.
The players
Walmart
A major American retail corporation and the nation's largest private employer that provides health benefits to 1.6 million workers.
Mayo Clinic
A prominent medical research and clinical care institution that will provide specialized neurological consultations for eligible employees.
Cleveland Clinic
A renowned academic medical center that will serve as a specialty consultation resource for employees with specific neurological diagnoses.
The details
The program covers essential medications for Type 2 diabetes, migraines, dementia, and cardiovascular conditions. To access diabetes treatments like Ozempic and Mounjaro at no cost, workers must undergo a prior approval process. Additionally, employees diagnosed with conditions such as MS, Parkinson's disease, or ALS will gain access to specialist consultations at Mayo Clinic or Cleveland Clinic.
Timeline
2026: Workers experienced a previous increase in insurance premiums.
2027: Walmart begins providing 250+ drugs free to employees and simultaneously increases insurance premiums.
Health Landscape
This policy arrives as eight in ten employers report that the rising cost of prescription drugs is driving their overall health benefit increases. The initiative stands in contrast to the trend where one in ten companies offering GLP-1 coverage expects to discontinue it by 2027.
If you are a Walmart employee, track the official documentation regarding the prior approval process for these diabetes medications before the program starts in 2027. It is worth discussing with your physician how these changes to your employer-provided benefits might align with your current long-term treatment plan.
The takeaway
The move to offer no-cost medications aims to ease the burden of managing chronic illnesses like Type 2 diabetes for a large segment of the U.S. workforce. Employees should monitor their specific benefits packages for information on the prior approval requirements necessary to access these treatments.
Further reading
For more information on managing chronic conditions, explore our Diabetes section.
Live Poll
Do you believe large employers have a responsibility to expand healthcare benefits for their employees?
